Stocks · Healthcare · Medical - Diagnostics & Research
Illumina, Inc. ILMN
$273.04 +2.75% Close, Oct 2, 2026 · NASDAQ · Market cap $41.31B
High qualityStrong trend
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +167.0%, ahead of the S&P 500 by 151.9 percentage points.
- Operating margin narrowed to 21.0% from 31.5% a year earlier.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +9.9%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 40%
- EPS growth (TTM, YoY)Bottom 32%
- FCF growth (TTM, YoY)Bottom 33%
- Revenue growth, 3-year CAGRBottom 20%
- Revenue growth accelerationTop 21%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 10%
- Gross marginTop 47%
- Operating marginTop 12%
- Cash conversion (OCF / net income)Bottom 37%
- Accruals (lower is better)Bottom 35%
- Net debt / EBITDA (lower is better)Top 48%
- Interest coverTop 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 24%
- Free-cash-flow yieldTop 29%
- EBITDA / enterprise valueTop 30%
- Sales / enterprise valueBottom 32%
- P/E vs own 5-year history (lower is better)Bottom 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 16%
- 6-month returnTop 7%
- 1-year return vs S&P 500Top 7%
- Distance from 52-week highTop 2%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 38%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 19%
- Upside to consensus price targetBottom 5%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 33%
- Maximum drawdown, 3 yearsTop 28%
- Beta vs S&P 500 (lower is better)Bottom 50%
- Net debt / EBITDA (lower is better)Top 48%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1.2% | 4.9% | ↑ |
| Gross margin | 67.1% | 66.8% | ↓ |
| Operating margin | 31.5% | 21.0% | ↓ |
| FCF margin | 24.1% | 20.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.9% | 1.2% | ↑ | Bottom 40% |
| EPS growth (TTM, YoY) | -32.2% | — | Bottom 32% | |
| Gross margin | 66.8% | 67.1% | ↓ | Top 47% |
| Operating margin | 21.0% | 31.5% | ↓ | Top 12% |
| Net margin | 18.4% | 29.4% | ↓ | — |
| Free-cash-flow margin | 20.9% | 24.1% | ↓ | — |
| Return on invested capital | 13.5% | — | Top 10% | |
| Revenue growth, 3-year CAGR | -1.8% | — | Bottom 20% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.33×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.09×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 12.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.38%
- Shareholder yield
- 0.38%
- Share count change, 1 year
- -2.5%
- Share count change, 3-year CAGR
- -1.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 28, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +9.9%
- Average 2-day reaction, last 8
- +2.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $237.00
- Target vs current price
- -13.2%
- Analysts with a rating
- 50
- Share rating Buy or Strong Buy
- 54%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +6.5% | +5.3% | +2.6% | +15.4% | — |
| Apr 30, 2026 | +9.5% | +5.3% | +18.5% | +31.8% | +57.4% |
| Feb 5, 2026 | +8.9% | -0.4% | -13.3% | -4.4% | +1.2% |
| Oct 30, 2025 | +14.5% | +4.2% | +28.8% | +36.6% | +60.0% |
| Jul 31, 2025 | +16.7% | -3.7% | -11.5% | -6.7% | -6.3% |
| May 8, 2025 | +3.2% | +4.2% | +2.4% | +7.7% | +28.9% |
| Feb 6, 2025 | -6.5% | -1.5% | -16.9% | -32.1% | -37.5% |
| Nov 4, 2024 | +29.7% | +2.5% | +0.9% | -3.1% | -11.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $1.31 | $1.23 | +6.5% | $1.16B |
| Apr 30, 2026 | $1.15 | $1.05 | +9.5% | $1.09B |
| Feb 5, 2026 | $1.35 | $1.24 | +8.9% | $1.16B |
| Oct 30, 2025 | $1.34 | $1.17 | +14.5% | $1.08B |
| Jul 31, 2025 | $1.19 | $1.02 | +16.7% | $1.06B |
| May 8, 2025 | $0.97 | $0.94 | +3.2% | $1.04B |
| Feb 6, 2025 | $0.86 | $0.92 | -6.5% | $1.10B |
| Nov 4, 2024 | $1.14 | $0.88 | +29.7% | $1.08B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 50.9× | 38.3× | 56th | Top 24% |
| P/E (forward) | 51.0× | — | — | — |
| EV / EBITDA | 31.4× | — | — | Top 30% |
| EV / Sales | 9.53× | — | — | Bottom 32% |
| Free-cash-flow yield | 2.27% | — | — | Top 29% |
| Earnings yield | 1.96% | — | — | Top 24% |
P/E over the past five years
Range 12.0× – 92.6× since Jul 4, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +167.0%
- Earnings per share growth (TTM)
- -32.2%
- Change in P/E multiple
- +219.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 108
- Days above the 200-day average
- 240
- 50-day average slope (20 days)
- +10.9%
- 200-day average slope (20 days)
- +7.5%
- Distance from 50-day average
- +24.7%
- Distance from 200-day average
- +67.8%
- RSI (14)
- 70.4
- Relative volume
- 0.69×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 46.5%
- Volatility vs own 5-year history
- 61th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.11
- Correlation with S&P 500
- 0.34
- Current drawdown from 1-year high
- -0.3%
- Maximum drawdown, 3 years
- -54.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 16, 2021 | Apr 8, 2025 | -86.2% | 915 days | Not yet recovered |
| Feb 12, 2021 | Mar 30, 2021 | -26.9% | 31 days | 89 days (Aug 5, 2021) |
| Oct 12, 2020 | Oct 30, 2020 | -16.9% | 14 days | 31 days (Dec 15, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $41.31B
- P/E (TTM)
- 50.9
- EPS, diluted (TTM)
- $5.36
- Revenue (TTM)
- $4.49B
- 52-week range
- $88.00 – $280.17
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $4.53B | $4.58B | $4.50B | $4.37B | $4.34B |
| Gross profit | $3.15B | $2.97B | $2.74B | $2.86B | $2.89B |
| Operating income | -$123.0M | -$4.18B | -$1.07B | -$833.0M | $864.0M |
| Net income | $762.0M | -$4.40B | -$1.16B | -$1.22B | $850.0M |
| EPS (diluted) | $5.05 | -$28.05 | -$7.35 | -$7.69 | $5.45 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.10B | $1.04B | $1.06B | $1.08B | $1.16B | $1.09B | $1.16B |
| Net income | $705.0M | $187.0M | $131.0M | $235.0M | $150.0M | $334.0M | $134.0M | $207.0M |
| EPS (diluted) | $4.41 | $1.17 | $0.82 | $1.50 | $0.97 | $2.17 | $0.87 | $1.35 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $545.0M | $392.0M | $478.0M | $837.0M | $1.08B |
| Capital expenditure | -$208.0M | -$286.0M | -$195.0M | -$128.0M | -$148.0M |
| Free cash flow | $337.0M | $106.0M | $282.0M | $709.0M | $931.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $60.0M | $63.0M | $67.0M | -$60.0M | -$698.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.17B
- Total assets
- $6.65B
- Total liabilities
- $3.81B
- Total debt
- $2.53B
- Net debt
- $1.49B
- Shareholders’ equity
- $2.84B
As of Jun 28, 2026 (filed Jul 31, 2026).
Short interest
- Shares sold short
- 10,585,422
- Days to cover
- 5.60
- Change vs previous report
- +8.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Sep 23, 2008
- 2-for-1